Your shopping cart is currently empty

Chrexanthomycin A is a marine natural product with notable biological activity and oral bioavailability. It exhibits binding affinities to DNA (G4C2)4G4 and RNA (G4C2)2G4 with Kd values of 2.2 mM and 3.0 mM, respectively. Chrexanthomycin A can be utilized for research on neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Chrexanthomycin A is a marine natural product with notable biological activity and oral bioavailability. It exhibits binding affinities to DNA (G4C2)4G4 and RNA (G4C2)2G4 with Kd values of 2.2 mM and 3.0 mM, respectively. Chrexanthomycin A can be utilized for research on neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). |
| In vitro | Chrexanthomycin A (Compounds cA) effectively binds to DNA (G4C2) 4 G4 and RNA (G4C2) 2 G4, with dissociation constants (K d) of 2.2 mM and 3.0 mM, respectively. It demonstrates high cell permeability and low cytotoxicity. At 1.61 μM, Chrexanthomycin A rescues G4C2 EHR-related cellular pathologies. It selectively interacts with G4C2 G4 structures in both DNA and RNA. In a concentration range of 0-100 μM, it significantly reduces cell death induced by G4C2 EHR, diminishes RNA foci in (G4C2)29-expressing Neuro2a cells, and effectively reduces reactive oxygen species (ROS) in HT22 cells. In a Cell Cytotoxicity Assay on HEK293T cells at concentrations of 0.16, 1.61, and 16.13 μM for 24 hours, it showed no cytotoxicity up to 10 μg/mL. |
| In vivo | Chrexanthomycin A (Compounds cA) at a concentration of 100 μM, administered through feeding, effectively mitigates eye degeneration and enhances locomotor performance in subjects expressing (G4C2)29. |
| Formula | C31H24O14 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.